Trial wraps up for pharmacist in deadly
U.S. meningitis outbreak
Send a link to a friend
[October 20, 2017]
By Nate Raymond
BOSTON (Reuters) - Closing arguments are
set for Friday in the trial of a Massachusetts pharmacist accused of
murder and fraud for his role in a 2012 fungal meningitis outbreak that
killed 76 people and sickened hundreds more across the United States.
Federal prosecutors in Boston contend that Glenn Chin, a former
supervisory pharmacist at New England Compounding Center, cut corners
while overseeing the production of drugs the company produced in filthy
conditions.
Those drugs included steroids tainted with mold that were shipped out to
healthcare facilities nationally and then injected into patients,
leading to an outbreak that sickened 778 people nationally, prosecutors
said.
They said that Chin, 49, recklessly failed to ensure the compounding
pharmacy's drugs were produced in sanitary conditions to keep up with
demand from hospitals for its products.
Prosecutors claim Chin directed staff in NECC's so-called clean rooms
where the drugs were made, to skip cleaning, despite the presence of
insects, mice and mold.
Chin has pleaded not guilty to charges including racketeering and mail
fraud. He faces up to life in prison if he is convicted of second-degree
murder charges brought under racketeering law.
Defense lawyers counter that Chin did nothing to kill the 25 people who
are the subject of those murder allegations and say blame instead lies
with Barry Cadden, NECC's co-founder and former president.
[to top of second column] |
Former New England Compounding Center supervisory pharmacist Glenn
Chin enters the federal court in Boston, Massachusetts, U.S.,
September 19, 2017. REUTERS/Nate Raymond/File Photo
They say that Cadden directed the corner-cutting at NECC, and note
that at his trial earlier this year, prosecutors said people died
because Cadden decided to put profits before patient safety.
Cadden was sentenced in June to nine years in prison after he was
found guilty of racketeering and fraud charges but cleared of
murder.
Lesser charges were filed against 12 other people. Three have
pleaded guilty, while a federal judge dismissed charges against two
defendants in October 2016. Charges remain pending against the other
seven.
(Reporting by Nate Raymond; Editing by Scott Malone and Bernadette
Baum)
[© 2017 Thomson Reuters. All rights
reserved.]
Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|